152 related articles for article (PubMed ID: 8483557)
1. First-line and salvage therapy of metastatic breast cancer with mitomycin/vinblastine.
Sedlacek SM
Oncology; 1993 Apr; 50 Suppl 1():16-21. PubMed ID: 8483557
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer.
Nabholtz JM; Thuerlimann B; Bezwoda WR; Melnychuk D; Deschênes L; Douma J; Vandenberg TA; Rapoport B; Rosso R; Trillet-Lenoir V; Drbal J; Aapro MS; Alaki M; Murawsky M; Riva A
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):25-30. PubMed ID: 9364538
[TBL] [Abstract][Full Text] [Related]
3. MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer.
Hsu C; Yeh KH; Hong RL; Yang CH; Lin MT; Chen YC; Cheng AL
J Formos Med Assoc; 1997 Mar; 96(3):185-8. PubMed ID: 9080756
[TBL] [Abstract][Full Text] [Related]
4. Mitomycin C and vinblastine in the treatment of advanced breast cancer.
Radford JA; Knight RK; Rubens RD
Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1475-7. PubMed ID: 3938396
[TBL] [Abstract][Full Text] [Related]
5. Salvage therapy for metastatic disease.
Sedlacek SM
Semin Oncol; 1990 Aug; 17(4 Suppl 7):45-9. PubMed ID: 2200132
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy with mitomycin-C, epidoxorubicin and vinblastine in CMF failing breast cancer patients.
Pronzato P; Amoroso D; Bertelli G; Queirolo P; Sertoli MR; Rosso R
Anticancer Res; 1990; 10(6):1743-5. PubMed ID: 2126683
[TBL] [Abstract][Full Text] [Related]
7. Failure of mitomycin-vindesine combination chemotherapy as salvage treatment for metastatic breast cancer.
Ardizzoni A; Pronzato P; Canobbio L; Lionetto R; Rosso R
J Cancer Res Clin Oncol; 1985; 110(1):77-8. PubMed ID: 4019571
[TBL] [Abstract][Full Text] [Related]
8. Mitomycin-C and vinblastine in advanced breast cancer.
Navarro M; Bellmunt J; Balañá C; Colomer R; Jolis L; del Campo JM
Oncology; 1989; 46(3):137-42. PubMed ID: 2497417
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.
Garewal HS; Brooks RJ; Jones SE; Miller TP
J Clin Oncol; 1983 Dec; 1(12):772-5. PubMed ID: 6422004
[TBL] [Abstract][Full Text] [Related]
10. Mitomycin C and vinblastine chemotherapy for advanced breast cancer.
Konits PH; Aisner J; van Echo DA; Lichtenfeld K; Wiernik PH
Cancer; 1981 Sep; 48(6):1295-8. PubMed ID: 6791808
[TBL] [Abstract][Full Text] [Related]
11. Mitomycin C and vinblastine in advanced refractory breast cancer.
Brambilla C; Zambetti M; Ferrari L; Bonadonna G
Tumori; 1989 Apr; 75(2):141-4. PubMed ID: 2500762
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of mitomycin C and vinblastine in women with advanced breast cancer refractory to standard cytotoxic therapy.
Denefrio JM; East DR; Troner MB; Vogel CL
Cancer Treat Rep; 1978 Dec; 62(12):2113-5. PubMed ID: 751719
[TBL] [Abstract][Full Text] [Related]
14. [Acute dyspnea following intravenous administration of vinblastine/mitomycin C].
Lagler U; Gattiker HH
Schweiz Med Wochenschr; 1989 Mar; 119(9):290-2. PubMed ID: 2496465
[TBL] [Abstract][Full Text] [Related]
15. Mitomycin C and vinblastine in combination with amifostine in metastatic breast cancer. A feasibility study of the EORTC--Investigational Drug Branch for Breast Cancer (IDBBC).
Kusenda Z; Kerger J; Awada A; Geurs F; Van Vreckem A; Habboubi N; Piccart MJ
Support Care Cancer; 1997 Sep; 5(5):414-6. PubMed ID: 9322355
[TBL] [Abstract][Full Text] [Related]
16. Dibromodulcitol, mitomycin C and vinblastine (DMV) chemotherapy in advanced breast cancer.
Howell A; Morrison JM; Bramwell VH; Harland RN; Moneypenny IJ
Eur J Cancer Clin Oncol; 1984 Jul; 20(7):873-6. PubMed ID: 6540188
[TBL] [Abstract][Full Text] [Related]
17. Mitomycin C in the chemotherapy of advanced breast cancer.
Garewal HS
Semin Oncol; 1988 Jun; 15(3 Suppl 4):74-9. PubMed ID: 3134698
[TBL] [Abstract][Full Text] [Related]
18. Hemolytic-uremic syndrome and acute renal failure in metastatic adenocarcinoma treated with mitomycin: case report and literature review.
D'Elia JA; Aslani M; Schermer S; Cloud L; Bothe A; Dzik W
Ren Fail; 1987; 10(2):107-13. PubMed ID: 3120247
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin, doxorubicin, and vinblastine as second-line chemotherapy in patients with advanced breast cancer.
Borovik R; Epelbaum R; Cohen Y; Robinson E
Cancer Treat Rep; 1986 Apr; 70(4):517-8. PubMed ID: 3698045
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer.
Keller AM; Mennel RG; Georgoulias VA; Nabholtz JM; Erazo A; Lluch A; Vogel CL; Kaufmann M; von Minckwitz G; Henderson IC; Mellars L; Alland L; Tendler C
J Clin Oncol; 2004 Oct; 22(19):3893-901. PubMed ID: 15459210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
